132 related articles for article (PubMed ID: 30797177)
21. Maternal hemodynamic changes following treatment by laser coagulation of placental vascular anastomoses and amnioreduction in twin-to-twin transfusion syndrome.
Nizard J; Gussi I; Ville Y
Ultrasound Obstet Gynecol; 2006 Oct; 28(5):670-3. PubMed ID: 17001754
[TBL] [Abstract][Full Text] [Related]
22. Feasibility of continuous intra-uterine pressure measurements during amnioreduction in twin-to-twin transfusion syndrome therapy.
Pohl M; Greimel P; Klaritsch P; Csapó B; Simonis H; Schneditz D
Placenta; 2023 Oct; 142():147-153. PubMed ID: 37801953
[TBL] [Abstract][Full Text] [Related]
23. Fetal urine and amniotic fluid in monochorionic twins with twin-twin transfusion syndrome: simulations of therapy.
Umur A; van Gemert MJ; Ross MG
Am J Obstet Gynecol; 2001 Oct; 185(4):996-1003. PubMed ID: 11641691
[TBL] [Abstract][Full Text] [Related]
24. Amnioreduction: how much to drain?
Abdel-Fattah SA; Carroll SG; Kyle PM; Soothill PW
Fetal Diagn Ther; 1999; 14(5):279-82. PubMed ID: 10529570
[TBL] [Abstract][Full Text] [Related]
25. Polyhydramnios: Causes, Diagnosis and Therapy.
Hamza A; Herr D; Solomayer EF; Meyberg-Solomayer G
Geburtshilfe Frauenheilkd; 2013 Dec; 73(12):1241-1246. PubMed ID: 24771905
[TBL] [Abstract][Full Text] [Related]
26. Normal amniotic pressure throughout gestation.
Fisk NM; Ronderos-Dumit D; Tannirandorn Y; Nicolini U; Talbert D; Rodeck CH
Br J Obstet Gynaecol; 1992 Jan; 99(1):18-22. PubMed ID: 1547165
[TBL] [Abstract][Full Text] [Related]
27. Idiopathic polyhydramnios and postnatal abnormalities.
Abele H; Starz S; Hoopmann M; Yazdi B; Rall K; Kagan KO
Fetal Diagn Ther; 2012; 32(4):251-5. PubMed ID: 22760013
[TBL] [Abstract][Full Text] [Related]
28. Acute recurrent polyhydramnios and amniotic prolactin.
De Santis M; Cavaliere AF; Noia G; Masini L; Menini E; Caruso A
Prenat Diagn; 2000 Apr; 20(4):347-8. PubMed ID: 10740211
[TBL] [Abstract][Full Text] [Related]
29. Amniotic fluid abnormalities.
Harman CR
Semin Perinatol; 2008 Aug; 32(4):288-94. PubMed ID: 18652930
[TBL] [Abstract][Full Text] [Related]
30. Amniotic Aaquaporins (AQP) in Normal and Pathological Pregnancies: Interest in Polyhydramnios.
Guibourdenche J; Bonnet-Serrano F; Younes Chaouch L; Sapin V; Tsatsaris V; Combarel D; Laguillier C; Grange G
Reprod Sci; 2021 Oct; 28(10):2929-2938. PubMed ID: 34254277
[TBL] [Abstract][Full Text] [Related]
31. Intrauterine manometry: technique and application to fetal pathology.
Nicolini U; Fisk NM; Talbert DG; Rodeck CH; Kochenour NK; Greco P; Hubinont C; Santolaya J
Prenat Diagn; 1989 Apr; 9(4):243-54. PubMed ID: 2654909
[TBL] [Abstract][Full Text] [Related]
32. SMFM Consult Series #46: Evaluation and management of polyhydramnios.
; Dashe JS; Pressman EK; Hibbard JU
Am J Obstet Gynecol; 2018 Oct; 219(4):B2-B8. PubMed ID: 30048635
[TBL] [Abstract][Full Text] [Related]
33. Indomethacin therapy in the treatment of symptomatic polyhydramnios.
Kirshon B; Mari G; Moise KJ
Obstet Gynecol; 1990 Feb; 75(2):202-5. PubMed ID: 2405320
[TBL] [Abstract][Full Text] [Related]
34. Severity of polyhydramnios does not affect the prevalence of large-for-gestational-age newborn infants.
Lazebnik N; Hill LM; Guzick D; Martin JG; Many A
J Ultrasound Med; 1996 May; 15(5):385-8. PubMed ID: 8731446
[TBL] [Abstract][Full Text] [Related]
35. Amnioreduction in emergency cerclage with prolapsed membranes: comparison of two methods for reducing the membranes.
Locatelli A; Vergani P; Bellini P; Strobelt N; Arreghini A; Ghidini A
Am J Perinatol; 1999; 16(2):73-7. PubMed ID: 10355913
[TBL] [Abstract][Full Text] [Related]
36. [Pregnancy complicated with symptomatic polyhydramnios: treatment with indomethacin].
Vigil-de Gracia PE; Campos-Rivera P; Lasso-de la Vega J
Ginecol Obstet Mex; 1997 Jan; 65():21-6. PubMed ID: 9072505
[TBL] [Abstract][Full Text] [Related]
37. Role of amnioinfusion in the management of premature rupture of the membranes at <26 weeks' gestation.
Locatelli A; Vergani P; Di Pirro G; Doria V; Biffi A; Ghidini A
Am J Obstet Gynecol; 2000 Oct; 183(4):878-82. PubMed ID: 11035330
[TBL] [Abstract][Full Text] [Related]
38. Alteration of the amniotic fluid and neonatal outcome.
Volante E; Gramellini D; Moretti S; Kaihura C; Bevilacqua G
Acta Biomed; 2004; 75 Suppl 1():71-5. PubMed ID: 15301296
[TBL] [Abstract][Full Text] [Related]
39. Amniotic fluid "sludge"; prevalence and clinical significance of it in asymptomatic patients at high risk for spontaneous preterm delivery.
Adanir I; Ozyuncu O; Gokmen Karasu AF; Onderoglu LS
J Matern Fetal Neonatal Med; 2018 Jan; 31(2):135-140. PubMed ID: 28064548
[TBL] [Abstract][Full Text] [Related]
40. Comparison between maternal and neonatal outcome of PPROM in the cases of amniotic fluid index (AFI) of more and less than 5 cm.
Mousavi AS; Hashemi N; Kashanian M; Sheikhansari N; Bordbar A; Parashi S
J Obstet Gynaecol; 2018 Jul; 38(5):611-615. PubMed ID: 29426264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
